vs
Side-by-side financial comparison of INSEEGO CORP. (INSG) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $48.4M, roughly 1.3× INSEEGO CORP.). INSEEGO CORP. runs the higher net margin — 1.0% vs -16.4%, a 17.4% gap on every dollar of revenue. On growth, ORTHOPEDIATRICS CORP posted the faster year-over-year revenue change (17.0% vs 0.6%). INSEEGO CORP. produced more free cash flow last quarter ($11.6M vs $9.7M). Over the past eight quarters, ORTHOPEDIATRICS CORP's revenue compounded faster (17.4% CAGR vs 13.6%).
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
INSG vs KIDS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $48.4M | $61.6M |
| Net Profit | $469.0K | $-10.1M |
| Gross Margin | 42.2% | 73.2% |
| Operating Margin | 2.7% | -13.3% |
| Net Margin | 1.0% | -16.4% |
| Revenue YoY | 0.6% | 17.0% |
| Net Profit YoY | 182.9% | 37.1% |
| EPS (diluted) | $-0.02 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $61.6M | ||
| Q3 25 | $45.9M | $61.3M | ||
| Q2 25 | $40.2M | $61.1M | ||
| Q1 25 | $31.7M | $52.4M | ||
| Q4 24 | $48.1M | $52.7M | ||
| Q3 24 | $54.0M | $54.6M | ||
| Q2 24 | $51.6M | $52.8M | ||
| Q1 24 | $37.5M | $44.7M |
| Q4 25 | $469.0K | $-10.1M | ||
| Q3 25 | $1.4M | $-11.8M | ||
| Q2 25 | $507.0K | $-7.1M | ||
| Q1 25 | $-1.6M | $-10.7M | ||
| Q4 24 | $-566.0K | $-16.1M | ||
| Q3 24 | $9.0M | $-7.9M | ||
| Q2 24 | $624.0K | $-6.0M | ||
| Q1 24 | $-4.5M | $-7.8M |
| Q4 25 | 42.2% | 73.2% | ||
| Q3 25 | 41.6% | 73.9% | ||
| Q2 25 | 41.1% | 72.1% | ||
| Q1 25 | 47.3% | 73.0% | ||
| Q4 24 | 37.3% | 67.5% | ||
| Q3 24 | 34.8% | 73.4% | ||
| Q2 24 | 36.4% | 77.3% | ||
| Q1 24 | 35.3% | 72.0% |
| Q4 25 | 2.7% | -13.3% | ||
| Q3 25 | 4.7% | -15.4% | ||
| Q2 25 | 3.2% | -17.4% | ||
| Q1 25 | -1.3% | -21.0% | ||
| Q4 24 | 3.7% | -26.7% | ||
| Q3 24 | 1.9% | -10.2% | ||
| Q2 24 | 3.6% | -10.7% | ||
| Q1 24 | -7.9% | -21.8% |
| Q4 25 | 1.0% | -16.4% | ||
| Q3 25 | 3.1% | -19.2% | ||
| Q2 25 | 1.3% | -11.6% | ||
| Q1 25 | -5.0% | -20.3% | ||
| Q4 24 | -1.2% | -30.5% | ||
| Q3 24 | 16.6% | -14.5% | ||
| Q2 24 | 1.2% | -11.4% | ||
| Q1 24 | -11.9% | -17.5% |
| Q4 25 | $-0.02 | $-0.43 | ||
| Q3 25 | $0.03 | $-0.50 | ||
| Q2 25 | $-0.03 | $-0.30 | ||
| Q1 25 | $-0.16 | $-0.46 | ||
| Q4 24 | $0.62 | $-0.70 | ||
| Q3 24 | $-0.06 | $-0.34 | ||
| Q2 24 | $-0.02 | $-0.26 | ||
| Q1 24 | $-0.44 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.9M | $60.9M |
| Total DebtLower is stronger | — | $106.0M |
| Stockholders' EquityBook value | $-4.0M | $346.6M |
| Total Assets | $93.8M | $508.6M |
| Debt / EquityLower = less leverage | — | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.9M | $60.9M | ||
| Q3 25 | $14.6M | $57.7M | ||
| Q2 25 | $13.2M | $70.1M | ||
| Q1 25 | $35.1M | $58.8M | ||
| Q4 24 | $39.6M | $68.8M | ||
| Q3 24 | $12.0M | $76.1M | ||
| Q2 24 | $49.0M | $28.9M | ||
| Q1 24 | $12.3M | $47.7M |
| Q4 25 | — | $106.0M | ||
| Q3 25 | — | $105.3M | ||
| Q2 25 | — | $102.7M | ||
| Q1 25 | — | $77.4M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $76.9M | ||
| Q2 24 | — | $11.2M | ||
| Q1 24 | — | $11.3M |
| Q4 25 | $-4.0M | $346.6M | ||
| Q3 25 | $-7.7M | $349.3M | ||
| Q2 25 | $-10.5M | $355.5M | ||
| Q1 25 | $-13.0M | $347.1M | ||
| Q4 24 | $-12.9M | $354.6M | ||
| Q3 24 | $-85.1M | $370.9M | ||
| Q2 24 | $-101.8M | $371.3M | ||
| Q1 24 | $-105.6M | $370.6M |
| Q4 25 | $93.8M | $508.6M | ||
| Q3 25 | $85.8M | $493.5M | ||
| Q2 25 | $83.1M | $503.6M | ||
| Q1 25 | $93.0M | $470.3M | ||
| Q4 24 | $100.0M | $473.2M | ||
| Q3 24 | $113.4M | $489.3M | ||
| Q2 24 | $149.6M | $430.8M | ||
| Q1 24 | $122.1M | $437.2M |
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.03× | ||
| Q1 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $12.0M | $10.3M |
| Free Cash FlowOCF − Capex | $11.6M | $9.7M |
| FCF MarginFCF / Revenue | 24.0% | 15.8% |
| Capex IntensityCapex / Revenue | 0.7% | 1.0% |
| Cash ConversionOCF / Net Profit | 25.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.5M | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.0M | $10.3M | ||
| Q3 25 | $3.2M | $-581.0K | ||
| Q2 25 | $-4.5M | $-10.5M | ||
| Q1 25 | $-3.5M | $-4.2M | ||
| Q4 24 | $-14.2M | $-4.0M | ||
| Q3 24 | $14.8M | $-10.3M | ||
| Q2 24 | $27.6M | $-6.1M | ||
| Q1 24 | $5.2M | $-6.7M |
| Q4 25 | $11.6M | $9.7M | ||
| Q3 25 | $3.1M | $-3.4M | ||
| Q2 25 | $-4.7M | $-13.9M | ||
| Q1 25 | $-3.5M | $-8.4M | ||
| Q4 24 | $-14.3M | $-4.2M | ||
| Q3 24 | $14.8M | $-11.7M | ||
| Q2 24 | $27.6M | $-12.8M | ||
| Q1 24 | — | $-13.2M |
| Q4 25 | 24.0% | 15.8% | ||
| Q3 25 | 6.7% | -5.6% | ||
| Q2 25 | -11.6% | -22.8% | ||
| Q1 25 | -11.0% | -16.0% | ||
| Q4 24 | -29.7% | -8.1% | ||
| Q3 24 | 27.4% | -21.4% | ||
| Q2 24 | 53.5% | -24.2% | ||
| Q1 24 | — | -29.4% |
| Q4 25 | 0.7% | 1.0% | ||
| Q3 25 | 0.2% | 4.6% | ||
| Q2 25 | 0.5% | 5.6% | ||
| Q1 25 | 0.1% | 8.1% | ||
| Q4 24 | 0.1% | 0.5% | ||
| Q3 24 | 0.0% | 2.5% | ||
| Q2 24 | 0.0% | 12.7% | ||
| Q1 24 | 0.0% | 14.5% |
| Q4 25 | 25.50× | — | ||
| Q3 25 | 2.22× | — | ||
| Q2 25 | -8.81× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 44.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.